| Trial ID: | L4287 |
| Source ID: | NCT01269996
|
| Associated Drug: |
Janumet, Lantus
|
| Title: |
JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients
|
| Acronym: |
JUBILEE
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Janumet, Lantus|DRUG: metformin, gliclazide, protaphane
|
| Outcome Measures: |
Primary: To evaluate the treatment efficacy, The change in HbA1c in 1 year compare to baseline., one year | Secondary: proportion of patients with HbA1c <6.5% in 1 year, Secondary Outcome Measure: The proportion of patients with HbA1c \<6.5% in 1 year. Other outcome measures: a)The change in body weight compare to baseline. b)Frequency of hypoglycaemia . Hypoglycemia is defined according to the ADA definitions and classifications of hypoglycaemia., one year
|
| Sponsor/Collaborators: |
Sponsor: Chinese University of Hong Kong
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
71
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-05
|
| Completion Date: |
2015-02
|
| Results First Posted: |
|
| Last Update Posted: |
2015-08-24
|
| Locations: |
Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong
|
| URL: |
https://clinicaltrials.gov/show/NCT01269996
|
